Lead
Dr. Salvador Plasencia, 44, is scheduled to be the first of five defendants sentenced in federal court in Los Angeles after pleading guilty to selling ketamine to actor Matthew Perry in the weeks before Perry’s overdose death on Oct. 28, 2023. Prosecutors are seeking a three-year prison term; the judge may hear statements from Perry’s family and others before imposing sentence. Plasencia admitted in a July plea that he illegally sold large quantities of ketamine to Perry but was not accused of supplying the dose investigators say caused the fatal overdose. The case centers on how a licensed clinician’s conduct intersected with a long-running substance use struggle for a high-profile patient.
Key takeaways
- Dr. Salvador Plasencia, 44, pleaded guilty in July to four counts of distribution of ketamine; prosecutors dropped five other counts as part of the plea deal.
- Prosecutors have recommended a three-year prison sentence; legally, the judge can impose up to 40 years on the remaining counts.
- Matthew Perry died on Oct. 28, 2023; court filings say Plasencia sold Perry large amounts of ketamine in the weeks before that date but was not charged with providing the dose investigators say killed him.
- Perry had been using ketamine legally for depression before seeking larger quantities after his regular physician refused the amounts he requested.
- Court documents include a text in which Plasencia described Perry in disparaging terms and acknowledged exploiting his vulnerability for money, according to prosecutors.
- Plasencia’s lawyers submitted character letters and described him as a physician who rose from poverty and now suffers professional and personal losses, including loss of his medical license.
- Five defendants reached guilty pleas in the broader investigation; Plasencia will be followed by four others who will be sentenced in coming months.
Background
Matthew Perry became a household name as Chandler Bing on NBC’s “Friends,” which aired from 1994 to 2004. His struggles with addiction spanned years and were publicly documented; he sought medical treatment for depression and, at times, for substance use. Ketamine, a surgical anesthetic that has been used off-label and in controlled settings to treat depression, also carries risks when diverted or used outside prescribed regimens.
Federal law prohibits unauthorized distribution of controlled substances; physicians who sell or divert drugs can face criminal charges, loss of licensure and civil liability. The probe into Perry’s death led investigators to multiple people who later reached plea agreements. In court filings, prosecutors framed Plasencia’s actions as taking advantage of a patient with a known addiction, while defense filings emphasized his prior charitable work and the personal consequences he has faced since the case became public.
Main event
The sentencing hearing in Los Angeles will determine Plasencia’s punishment after his July guilty plea on four distribution counts. Prosecutors asked U.S. District Judge Sherilyn Peace Garnett to impose a three-year prison term, citing texts and other evidence they say show Plasencia knowingly supplied large quantities of ketamine to a vulnerable patient. Defense attorneys countered with a packet of testimonials describing Plasencia as a devoted physician who has expressed remorse and lost his clinic and medical license.
Court filings allege Plasencia sold ketamine to Perry when the actor’s regular doctor declined to provide the doses Perry sought. Prosecutors included messages that, they say, show a transactional approach to Perry’s care and call into question the doctor’s judgment when treating an addicted patient. The filings also note prosecutors did not allege Plasencia provided the specific dose investigators identified as fatal on Oct. 28, 2023.
Before the judge hands down a sentence, Perry’s family members and others affected by his death may address the court; Perry’s mother, Suzanne Perry, and his stepfather, journalist Keith Morrison, attended earlier hearings. The sentencing memorandum from prosecutors emphasized the exploitation of a patient with a long history of addiction, while the defense memo stressed Plasencia’s remorse and personal rehabilitation efforts.
If imprisoned, Plasencia would join a small but notable set of clinicians criminally charged for illegal drug distribution tied to patient harm. The remaining four defendants who pleaded guilty in the broader investigation will be sentenced separately in the coming months, leaving open questions about the scope of accountability beyond this case.
Analysis & implications
The case highlights tensions between expanding clinical uses of drugs like ketamine and the risks of diversion and misuse. Ketamine has gained attention as a rapid-acting treatment for severe depression, but its off-label and compounded uses can create regulatory blind spots that prosecutors and regulators are increasingly scrutinizing. High-profile outcomes, such as this prosecution, may prompt closer oversight from state medical boards and federal authorities over how such treatments are prescribed and dispensed.
For clinicians, the Plasencia case underscores legal and ethical obligations when treating patients with substance use histories. Prescribing decisions that prioritize patient safety over demand are central to professional standards; prosecutors in this case argue those boundaries were crossed. Medical boards may use criminal cases as part of licensure reviews, and civil litigants could point to criminal convictions in malpractice suits, increasing financial and professional exposure for practitioners.
Public perceptions of addiction treatment could also shift: some patients and advocates worry that heightened enforcement will chill clinicians from prescribing legitimately indicated therapies, while others argue stronger criminal consequences are necessary to deter exploitation. Policymakers might respond with clearer prescribing guidelines, enhanced physician education on addiction, or tighter controls on certain formulations and dispensing practices.
Comparison & data
| Item | Detail |
|---|---|
| Defendant age | 44 |
| Plea | Guilty (July) — 4 counts of distribution |
| Counts dropped | 5 counts dropped by prosecutors |
| Prosecutors’ recommendation | 3 years’ imprisonment |
| Maximum possible | Up to 40 years under remaining charges |
| Victim’s death | Oct. 28, 2023 |
The table summarizes court-recorded milestones in the Plasencia matter: plea timing, charge counts, recommended and potential sentences, and the date of Perry’s death. These discrete figures show the gap between the prosecutors’ requested sentence and the statutory maximum, reflecting plea negotiations that narrowed the number of counts but left judicial discretion intact. The summary also highlights how the criminal case timeline—Perry’s October 2023 death, a July guilty plea and staggered sentencing for multiple defendants—unfolded over months of investigation and negotiation.
Reactions & quotes
Prosecutors framed Plasencia’s conduct as an abuse of a patient with a known addiction, arguing that the defendant prioritized profit over care. Their sentencing memorandum singled to courts the doctor’s messages and conduct as evidence of exploitation rather than medical judgment.
“sought to exploit Perry’s medical vulnerability for profit”
U.S. prosecutors (court filing)
Defense attorneys asked the court to weigh Plasencia’s prior service, remorse and family responsibilities, noting that he has suffered professional ruin and personal threats since the investigation became public. In filings and a video submitted to the court, Plasencia expressed regret and emphasized his role as a father and caretaker since leaving medical practice.
“the biggest mistake of his life”
Defense filing
Members of Perry’s family have attended hearings and may address the court; their statements would be typical in federal sentencing to convey the human impact of the loss. The presence of family and public attention has been a recurrent element in this high-profile matter and may influence how the judge frames the case in sentencing remarks.
“I want him to be proud of his father”
Dr. Salvador Plasencia (video to court)
Unconfirmed
- Whether any of the other four defendants directly supplied the fatal dose to Perry remains subject to separate filings and hearings and has not been publicly established here.
- Timing and length of sentences for the other four defendants have not been finalized and will be determined at their individual hearings in coming months.
Bottom line
The sentencing of Dr. Salvador Plasencia underscores how criminal law can intersect with clinical practice when controlled substances are diverted or sold outside accepted medical protocols. Prosecutors emphasize exploitation of a vulnerable, addicted patient; the defense highlights remorse, career collapse and family consequences. The judge’s sentence will balance those factors within federal sentencing law and could shape how regulators and clinicians approach ketamine prescribing and addiction care going forward.
For patients, providers, and policymakers, the case is likely to prompt closer scrutiny of how emerging psychiatric treatments are controlled, documented and dispensed, and could accelerate calls for clearer guidelines and stronger safeguards to prevent diversion and exploitation.
Sources
- AP News (news reporting, based on court filings)